Weis Holger 4
4 · ZIOPHARM ONCOLOGY INC · Filed May 6, 2021
Insider Transaction Report
Form 4
Weis Holger
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-04+31,250→ 31,250 totalExercise: $4.31Exp: 2031-03-03→ Common Stock (31,250 underlying) - Award
Common Stock
2021-03-04+4,167→ 70,167 total - Award
Stock Option (right to buy)
2021-03-04+150,000→ 150,000 totalExercise: $4.31Exp: 2031-03-03→ Common Stock (150,000 underlying)
Holdings
- 19,000(indirect: By Spouse)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,240(indirect: By Children)
Common Stock
- 200(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]The shares will vest on 5/19/2021.
- [F2]Includes 30,000 shares held in a joint account by the Reporting Person and his spouse.
- [F3]1/3rd of the shares underlying this option will vest on 4/4/2021, 5/4/2021 and 5/19/2021.
- [F4]1/36th of the shares underlying this option will vest in equal monthly installments commencing one month after 12/15/2020.